Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in type 2 diabetes.

Saulnier PJ, Roussel R, Halimi JM, Lebrec J, Dardari D, Maimaitiming S, Guilloteau G, Prugnard X, Marechaud R, Ragot S, Marre M, Hadjadj S; SURDIAGENE, DIAB2NEPHROGENE, and DIABHYCAR study groups.

Diabetes Care. 2011 May;34(5):1199-204. doi: 10.2337/dc10-2057. Epub 2011 Apr 4.

2.

Zinc deficiency: a frequent and underestimated complication after bariatric surgery.

Sallé A, Demarsy D, Poirier AL, Lelièvre B, Topart P, Guilloteau G, Bécouarn G, Rohmer V.

Obes Surg. 2010 Dec;20(12):1660-70. doi: 10.1007/s11695-010-0237-5.

PMID:
20706804
3.

Resting energy expenditure is not increased in mildly hyperglycaemic obese diabetic patients.

Ryan M, Sallé A, Guilloteau G, Genaitay M, Livingstone MB, Ritz P.

Br J Nutr. 2006 Nov;96(5):945-8.

PMID:
17092386
4.

'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients.

Sallé A, Ryan M, Guilloteau G, Bouhanick B, Berrut G, Ritz P.

Br J Nutr. 2005 Dec;94(6):931-7.

PMID:
16351770
5.

Effect of insulin treatment on the body composition of Type 2 diabetic patients.

Sallé A, Guilloteau G, Ryan M, Bouhanick B, Ritz P.

Diabet Med. 2004 Dec;21(12):1298-303.

PMID:
15569132
6.

Proliferative retinopathy in patients with type 1 diabetes of less than 5 years' duration.

Bouhanick B, Bellanné-Chantelot C, Salle A, Guilloteau G, Ebran JM.

Diabetes Metab. 2002 Apr;28(2):141-4.

PMID:
11976567
7.

[Prevention of cardiovascular diseases in type 2 diabetes with aspirin].

Duly-Bouhanick B, Menard S, Hadjadj S, Soares-Barbosa S, Plun-Favreau J, Guilloteau G.

Presse Med. 2001 Jan 20;30(2):87-91. Review. French.

PMID:
11244821
8.

Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.

Hadjadj S, Belloum R, Bouhanick B, Gallois Y, Guilloteau G, Chatellier G, Alhenc-Gelas F, Marre M.

J Am Soc Nephrol. 2001 Mar;12(3):541-9.

9.

[Differences in glycemic balance (but not weight) correlate positively with changes in absolute cardiovascular risk in diabetic patients].

Hadjadj S, Guilloteau G, Weekers L, Bouhanick B, Fressinaud P, Marre M.

Arch Mal Coeur Vaiss. 2000 Aug;93(8):1033-6. French.

PMID:
10989752
10.

Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.

Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Bled F, Le Jeune JJ, Fressinaud P, Marre M.

Clin Nephrol. 1997 Aug;48(2):92-7.

PMID:
9285145
11.

Loss of the nocturnal decline in blood pressure in subjects with essential hypertension and microalbuminuria.

Berrut G, Bouhanick B, Fabbri P, Guilloteau G, Lalanne P, Marre M, Fressinaud P.

Blood Press Monit. 1996 Dec;1(6):469-473.

PMID:
10226277
12.

[Decrease of nocturnal blood pressure in type II diabetic subjects with microalbuminuria].

Berrut G, Fabbri P, Bouhanick B, Lalanne P, Guilloteau G, Marre M, Fressinaud P.

Arch Mal Coeur Vaiss. 1996 Aug;89(8):1041-4. French.

PMID:
8949375

Supplemental Content

Loading ...
Support Center